Free Trial

IceCure Medical (ICCM) Institutional Ownership

IceCure Medical logo
$0.60 -0.01 (-1.63%)
(As of 11/20/2024 ET)

Institutional Ownership Changes (13F Filings) for IceCure Medical (NASDAQ:ICCM)

Current
Institutional Ownership
Percentage
0.62%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$49.14K
Number of
Institutional Sellers
(last 12 months)
0
Get ICCM Insider Trade Alerts

Want to know when executives and insiders are buying or selling IceCure Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IceCure Medical Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/9/2024 Renaissance Technologies LLC66,400$49K0.0%N/A0.146%
2/14/2022Credit Suisse AG55,996$52.47M0.0%N/A0.000%
1/28/2022 ARK Investment Management LLC464,893$1.40M0.0%+48.4%0.000%
(Data available from 1/1/2016 forward)

ICCM Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ICCM shares?

During the previous two years, the following institutional investors and hedge funds held shares of IceCure Medical shares: Renaissance Technologies LLC ($49K).Learn more on ICCM's institutional investors.

What percentage of IceCure Medical stock is owned by institutional investors?

0.62% of IceCure Medical stock is owned by institutional investors. Learn more on ICCM's institutional investor holdings.

Which institutional investors have been buying IceCure Medical stock?

The following institutional investors have purchased IceCure Medical stock in the last 24 months: Renaissance Technologies LLC ($66.40K).

How much institutional buying is happening at IceCure Medical?

Institutional investors have bought a total of 66,400 shares in the last 24 months. This purchase volume represents approximately $49.14K in transactions.



This page (NASDAQ:ICCM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners